About Lokavant

Lokavant is a clinical trial intelligence platform that focuses on enhancing drug development through AI-driven analytics and real-time data insights. Founded in 2020 as a spinout from Roivant Sciences, Lokavant aims to improve the efficiency, cost, and quality of clinical trial planning and execution. The company has developed a proprietary dataset from thousands of de-identified clinical trials, enabling it to deliver predictive analytics with high confidence and accuracy.

The core offering is the Clinical Trial Intelligence Platform, a modular SaaS solution that consolidates and analyzes various trial data sources into a unified dashboard. Key features include Spectrum™, which forecasts study outcomes, Dynamic Enrollment for real-time site performance optimization, and Study Oversight for monitoring trial progress. Lokavant also provides tools for risk detection, medical monitoring, and ensuring diversity and inclusion in clinical trials. The platform has been adopted by leading organizations, including Parexel, for its capabilities in risk-based monitoring and data-driven insights.